StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
TD Cowen Reiterates Buy Rating on Biohaven Pharma (BHVN)
August 26, 2026 11:01 AM
TD Cowen analyst Tyler Van Buren reiterated a Buy rating and $30.00 price target on Biohaven Pharma (NYSE: BHVN)The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
